HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.

Abstract
Eradicating tumor dormancy that develops following epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment of EGFR-mutant non-small cell lung cancer, is an attractive therapeutic strategy but the mechanisms governing this process are poorly understood. Blockade of ERK1/2 reactivation following EGFR TKI treatment by combined EGFR/MEK inhibition uncovers cells that survive by entering a senescence-like dormant state characterized by high YAP/TEAD activity. YAP/TEAD engage the epithelial-to-mesenchymal transition transcription factor SLUG to directly repress pro-apoptotic BMF, limiting drug-induced apoptosis. Pharmacological co-inhibition of YAP and TEAD, or genetic deletion of YAP1, all deplete dormant cells by enhancing EGFR/MEK inhibition-induced apoptosis. Enhancing the initial efficacy of targeted therapies could ultimately lead to prolonged treatment responses in cancer patients.
AuthorsKari J Kurppa, Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi, Erik H Knelson, Yingtian Xie, Klothilda Lim, Paloma Cejas, Andrew Portell, Patrick H Lizotte, Scott B Ficarro, Shuai Li, Ting Chen, Heidi M Haikala, Haiyun Wang, Magda Bahcall, Yang Gao, Sophia Shalhout, Steffen Boettcher, Bo Hee Shin, Tran Thai, Margaret K Wilkens, Michelle L Tillgren, Mierzhati Mushajiang, Man Xu, Jihyun Choi, Arrien A Bertram, Benjamin L Ebert, Rameen Beroukhim, Pratiti Bandopadhayay, Mark M Awad, Prafulla C Gokhale, Paul T Kirschmeier, Jarrod A Marto, Fernando D Camargo, Rizwan Haq, Cloud P Paweletz, Kwok-Kin Wong, David A Barbie, Henry W Long, Nathanael S Gray, Pasi A Jänne
JournalCancer cell (Cancer Cell) Vol. 37 Issue 1 Pg. 104-122.e12 (01 13 2020) ISSN: 1878-3686 [Electronic] United States
PMID31935369 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Cell Cycle Proteins
  • Transcription Factors
  • YAP-Signaling Proteins
  • YAP1 protein, human
  • Yap1 protein, mouse
  • EGFR protein, human
  • ErbB Receptors
  • MAP Kinase Kinase 1
Topics
  • Adaptor Proteins, Signal Transducing (metabolism)
  • Animals
  • Apoptosis
  • Cell Cycle Proteins (metabolism)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • Cellular Senescence
  • Drug Resistance, Neoplasm
  • ErbB Receptors (metabolism)
  • Female
  • Gene Deletion
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms (metabolism, pathology)
  • MAP Kinase Kinase 1 (metabolism)
  • Male
  • Mice
  • Mice, Knockout
  • Mutation
  • Signal Transduction
  • Transcription Factors (metabolism)
  • Transcription, Genetic
  • YAP-Signaling Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: